FIELD: chemistry.
SUBSTANCE: invention relates to a novel crystalline modification of 4-hydroxo-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one with dimethylsulphoxide in molar ratio of 1:1, a method for production thereof and use as a rodenticide agents. Disclosed crystalline modification of solvate is characterized by the following values of parameters of the crystallographic cell: spatial group P 
a=9.409(1) 
b=9.833(1) c=10.989(1) α=104.514(1)°, β=98.568(1)°, γ=99.177(1)°, Z=2.
EFFECT: obtaining a new crystalline modification of warfarin with dimethyl sulphoxide with a molar ratio of 1:1, having higher biological effectiveness compared to a precursor (warfarin).
3 cl, 5 tbl, 2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| POLYMORPHOUS MODIFICATION OF 3,4-DIHYDRO-2-METHOXY-2-METHYL-4-PHENYL-2H,5H-PYRANO[3,2-C]BENZOPYRAN-5-ONE, METHOD FOR PRODUCTION THEREOF AND USE AS RODENTICIDE AGENT | 2019 |
|
RU2732014C1 |
| METHOD OF PRODUCING SODIUM SALT 4-HYDROXY-3-(3-OXO-1-PHENYLBUTYL)-2H-1-BENZOPYRAN-2-ONE | 2012 |
|
RU2487871C1 |
| ANTICOAGULANT AGENT OF INDIRECTLY ACTION BASED ON NEW HYBRID MOLECULE OF WARFARIN WITH ESSENTIAL ACID | 2018 |
|
RU2677647C1 |
| HYBRID COUMARINS WITH INDIRECT ANTICOAGULANT ACTION | 2018 |
|
RU2672062C1 |
| BENZYLAMMONIUM SALT OF 4-ETHOXYCARBONYL-5-OXO-2-(2-OXO-2-PHENYLETHYLIDENE)-2,5-DIHYDRO-1H-PYRROLE-3-OLATE, SHOWING ANTIMICROBIAL ACTIVITY | 2022 |
|
RU2781135C1 |
| USE OF SUBSTITUTED 2-(2-(4,4,6-TRIMETHYL-2-OXO-4N-PYRROLO[3,2,1-IJ]QUINOLINE-1(2H)-YLIDENE)HYDRAZINYL)THIAZOLE-4(5H)-ONES AS INHIBITORS OF BLOOD COAGULATION FACTORS XA AND XIA AND METHOD FOR THEIR PREPARATION | 2023 |
|
RU2819271C1 |
| PROCESS FOR PREPARING (±)-6-CYANO-3,4-DIHYDRO-2,2- DIMETHYL-TRANS-4-(2-OXO-1-PYRROLIDINYL)-2H-1-BENZOPYRAN- 3-OL | 1992 |
|
RU2041223C1 |
| IMPROVED METHOD OF PRODUCING 5-CHLOROPYRIDIN-3-YL-1N-INDOLE-4-CARBOXYLATE | 2023 |
|
RU2816391C1 |
| CONJUGATE OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITOR WITH ASIALOGLYCOPROTEIN RECEPTOR LIGAND | 2022 |
|
RU2816947C2 |
| NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION | 2017 |
|
RU2659388C1 |
